Osteoporosis after stem cell transplantation

Curr Osteoporos Rep. 2013 Dec;11(4):305-10. doi: 10.1007/s11914-013-0180-1.


With long-term survival for recipients of autologous and allogeneic hematopoietic cell transplantation (HCT) increasing, the recognition of late complications such as decreased bone mineral density leading to osteoporosis (OP) has also increased. With an incidence that is reported to affect as many 50 % of allo HCT recipients, studies continue to mount supporting the need and success in treatment of this HCT complication. In this review, we highlight the major pathological mechanisms behind the development of OP, its diagnosis, and the literature supporting consensus treatment recommendations while noting areas of uncertainty that need further research.

Publication types

  • Review

MeSH terms

  • Bone Density / physiology
  • Bone Remodeling / physiology
  • Disease Management
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Incidence
  • Osteoporosis / diagnosis*
  • Osteoporosis / epidemiology*
  • Osteoporosis / physiopathology
  • Risk Factors